On June 22, 2022, Better Therapeutics Inc. (NASDAQ: BTTX) opened at $1.55, higher 23.49% from the last session. During the day, the shares moved up to $2.00 and dropped to $1.50 before settling in for the closing price of $1.49. Price fluctuations for BTTX have ranged from $0.91 to $29.40 over the past 52 weeks.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Sponsored
Company’s average yearly earnings per share was noted 37.00% at the time writing. With a float of $10.63 million, this company’s outstanding shares have now reached $23.41 million.
Let’s look at the performance matrix of the company that is accounted for 44 employees.
Better Therapeutics Inc. (BTTX) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Better Therapeutics Inc. is 0.50%, while institutional ownership is 13.90%. The most recent insider transaction that took place on Jun 14, was worth 20,846. In this transaction Director of this company bought 15,000 shares at a rate of $1.39, taking the stock ownership to the 15,000 shares. Before that another transaction happened on Jun 13, when Company’s Director bought 25,000 for $1.45, making the entire transaction worth $36,182. This insider now owns 40,000 shares in total.
Better Therapeutics Inc. (BTTX) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/30/2021, the company posted -$0.71 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.46) by -$0.25. This company achieved a return on equity of -219.55. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 37.00% per share during the next fiscal year.
Better Therapeutics Inc. (NASDAQ: BTTX) Trading Performance Indicators
Check out the current performance indicators for Better Therapeutics Inc. (BTTX). In the past quarter, the stock posted a quick ratio of 9.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.15, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -3.98 in one year’s time.
Technical Analysis of Better Therapeutics Inc. (BTTX)
Better Therapeutics Inc. (NASDAQ: BTTX) saw its 5-day average volume 0.48 million, a negative change from its year-to-date volume of 3.62 million. As of the previous 9 days, the stock’s Stochastic %D was 43.63%. Additionally, its Average True Range was 0.26.
During the past 100 days, Better Therapeutics Inc.’s (BTTX) raw stochastic average was set at 22.16%, which indicates a significant decrease from 74.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 118.90% in the past 14 days, which was lower than the 207.34% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6277, while its 200-day Moving Average is $5.0671. Nevertheless, the first resistance level for the watch stands at $2.0600 in the near term. At $2.2800, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.5600. If the price goes on to break the first support level at $1.5600, it is likely to go to the next support level at $1.2800. Assuming the price breaks the second support level, the third support level stands at $1.0600.
Better Therapeutics Inc. (NASDAQ: BTTX) Key Stats
There are currently 23,607K shares outstanding in the company with a market cap of 47.21 million. Presently, the company’s annual sales total 0 K according to its annual income of -40,340 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -9,660 K.
